BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6360586)

  • 1. Vitamin E and retrolental fibroplasia: prevention of serious ocular sequelae.
    Finer NN; Peters KL; Schindler RF; Grant GD
    Ciba Found Symp; 1983; 101():147-64. PubMed ID: 6360586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E and necrotizing enterocolitis.
    Finer NN; Peters KL; Hayek Z; Merkel CL
    Pediatrics; 1984 Mar; 73(3):387-93. PubMed ID: 6546616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants.
    Hittner HM; Godio LB; Rudolph AJ; Adams JM; Garcia-Prats JA; Friedman Z; Kautz JA; Monaco WA
    N Engl J Med; 1981 Dec; 305(23):1365-71. PubMed ID: 7029275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrolental fibroplasia and vitamin E in the preterm infant--comparison of oral versus intramuscular:oral administration.
    Hittner HM; Speer ME; Rudolph AJ; Blifeld C; Chadda P; Holbein ME; Godio LB; Kretzer FL
    Pediatrics; 1984 Feb; 73(2):238-49. PubMed ID: 6546416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia. A controlled trial.
    Finer NN; Schindler RF; Grant G; Hill GB; Peters K
    Lancet; 1982 May; 1(8281):1087-91. PubMed ID: 6122890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraventricular hemorrhage and vitamin E in the very low-birth-weight infant: evidence for efficacy of early intramuscular vitamin E administration.
    Speer ME; Blifeld C; Rudolph AJ; Chadda P; Holbein ME; Hittner HM
    Pediatrics; 1984 Dec; 74(6):1107-12. PubMed ID: 6504632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less.
    Johnson L; Bowen FW; Abbasi S; Herrmann N; Weston M; Sacks L; Porat R; Stahl G; Peckham G; Delivoria-Papadopoulos M
    Pediatrics; 1985 Apr; 75(4):619-38. PubMed ID: 3885152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors in retrolental fibroplasia.
    Gunn TR; Easdown J; Outerbridge EW; Aranda JV
    Pediatrics; 1980 Jun; 65(6):1096-100. PubMed ID: 6892851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrolental fibroplasia: further clinical evidence and ultrastructural support for efficacy of vitamin E in the preterm infant.
    Hittner HM; Godio LB; Speer ME; Rudolph AJ; Taylor MM; Blifeld C; Kretzer FL
    Pediatrics; 1983 Mar; 71(3):423-32. PubMed ID: 6687494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial.
    Phelps DL; Rosenbaum AL; Isenberg SJ; Leake RD; Dorey FJ
    Pediatrics; 1987 Apr; 79(4):489-500. PubMed ID: 3547300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrolental fibroplasia and blood transfusion in very low-birth-weight infants.
    Sacks LM; Schaffer DB; Anday EK; Peckham GJ; Delivoria-Papadopoulos M
    Pediatrics; 1981 Dec; 68(6):770-4. PubMed ID: 6895663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PaO2 levels and retrolental fibroplasia: a report of the cooperative study.
    Kinsey VE; Arnold HJ; Kalina RE; Stern L; Stahlman M; Odell G; Driscoll JM; Elliott JH; Payne J; Patz A
    Pediatrics; 1977 Nov; 60(5):655-68. PubMed ID: 578921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low inspired oxygen concentrations in very-low-birthweight infants needing ventilatory support: an approach to the prevention of retrolental fibroplasia.
    MacMahon P; Fleming PJ; Speidel BD; Dunn PM
    Br J Obstet Gynaecol; 1986 Apr; 93(4):361-3. PubMed ID: 3754456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of retrolental fibroplasia by administration of water soluble vitamin E (preliminary report)].
    Hervei S; Bors Z; Ugrai M; Malik T; Czappán P; Bohár A; Véli M
    Orv Hetil; 1983 Apr; 124(14):811-2. PubMed ID: 6346217
    [No Abstract]   [Full Text] [Related]  

  • 15. [Retrolental fibroplasia--a preventable disease? (author's transl)].
    Wille L
    Klin Padiatr; 1981 Jul; 193(4):296-300. PubMed ID: 7021991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of blood transfusions to retrolental fibroplasia.
    Mittelman D; Cronin C
    Ann Ophthalmol; 1983 Apr; 15(4):376-8. PubMed ID: 6689255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrolental fibroplasia: an unsolved problem.
    Weiter JJ
    N Engl J Med; 1981 Dec; 305(23):1404-6. PubMed ID: 7029279
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of intramuscular vitamin E on mortality and intracranial hemorrhage in neonates of 1000 grams or less.
    Fish WH; Cohen M; Franzek D; Williams JM; Lemons JA
    Pediatrics; 1990 Apr; 85(4):578-84. PubMed ID: 2179850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of O2-exposed premature infants with and without vitamin E substitution from the ophthalmologic viewpoint].
    Burgold R; Krebs W; Menzel K
    Kinderarztl Prax; 1989 Feb; 57(2):71-6. PubMed ID: 2724777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lensectomy-vitrectomy for stage V cicatricial retrolental fibroplasia.
    Merritt JC; Lawson EE; Sprague DH; Eifrig DE
    Ophthalmic Surg; 1982 Apr; 13(4):300-6. PubMed ID: 6896560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.